Introduction: Risk Management vs. Risk Reaction Most clinical trials fail—not because of bad execution, but because of bad risk management. Yet, many sponsors and CROs still treat risk assessment as a one-time exercise instead of an ongoing, real-time strategy. The truth is risks will emerge in every clinical trial. The question is: Will you be […]
Introduction: The Need for Smarter Oversight Clinical trials are becoming increasingly complex, involving multiple stakeholders: sponsors, CROs, other service providers, and investigators, each playing a critical role in ensuring trial success. The challenge? Traditional oversight methods are no longer sufficient. Sponsors often rely on monitoring visits and compliance checklists, while some CROs execute predefined monitoring […]
Supervisar un ensayo clínico no debería ser como navegar a ciegas. En Qlarix, ayudamos a que los riesgos se anticipen y el camino se trace con precisión. Hemos tenido la oportunidad de ser entrevistados por Luis Fraga, de Asociación Nacional de CEEIs (ANCES), para hablar sobre nuestro proyecto en Qlarix y del mundo del emprendimiento. […]